My watch list
my.chemeurope.com  
Login  

[Policy Forum] CRISPR, surrogate licensing, and scientific discovery

Several institutions are embroiled in a legal dispute over the foundational patent rights to CRISPR-Cas9 gene-editing technology, and it may take years for their competing claims to be resolved (1–4). But even before ownership of the patents is finalized, the institutions behind CRISPR have wasted no time capitalizing on the huge market for this groundbreaking technology by entering into a series of license agreements with commercial enterprises (see the figure). With respect to the potentially lucrative market for human therapeutics and treatments, each of the key CRISPR patent holders has granted exclusive rights to a spinoff or “surrogate” company formed by the institution and one of its principal researchers (5, 6). Although this model, in which a university effectively outsources the licensing and commercialization of a valuable patent portfolio to a private company, is not uncommon in the world of university technology transfer, we suggest it could rapidly bottleneck the use of CRISPR technology to discover and develop useful human therapeutics. Authors: Jorge L. Contreras, Jacob S. Sherkow

Authors:   Jorge L. Contreras; Jacob S. Sherkow
Journal:   Science
Volume:   355
edition:   6326
Year:   2017
Pages:   698
DOI:   10.1126/science.aal4222
Publication date:   17-Feb-2017
Facts, background information, dossiers
More about Science International / AAAS
  • Publications

    Random number generators go public

    On 10 July, researchers in Chile will unveil an online public random number service. Later in July, the U.S. National Institute of Standards and Technology (NIST) will launch its Randomness Beacon as a permanent service, upgrading a pilot program that began in 2013. Brazil, too, is planning ... more

    When the cure kills—CBD limits biodiversity research

    The Convention on Biological Diversity (CBD) commits its 196 nation parties to conserve biological diversity, use its components sustainably, and share fairly and equitably the benefits from the utilization of genetic resources. The last of these objectives was further codified in the Conve ... more

    See-through solar cells could power offices

    Solar windows turn some of the light shining through into electricity. They've been on the market for years. But many of these windows absorb some visible light, leaving them with a reddish or brownish hue, a trait frowned on by architects. Now, new versions are on the way that absorb invis ... more

  • News

    It's Not an Illusion

    Researchers have developed a compound that can transform near-infrared light into broadband white-light, offering a cheap, efficient means to produce visible light. The emitted light is also exceedingly directional, a desirable quality for devices like microscopes that require high spatial ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE